Angela Smith, MD
Urology · Chapel Hill, NCNPI 1902008154
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,000 of the $7,743 with a category attached, or 64.6%. Photocure Inc accounts for 67.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $5,222 and has fallen 99.6% since, to $21 in 2023.
Across 8 payments — averaging $967.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Photocure Inc$5K
- Ambu Inc.$2K
- Merck$1K
- Koelis Inc.$21
Across 18 payments — averaging $23,354 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$396K
- Merck$24K
What the payments were for
- Consulting fees$2,50032%
- Speaking & faculty fees$5,00065%
- Food & beverage$2433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Photocure Inc | 5 | $5,222 |
| Ambu Inc. | 1 | $1,500 |
| Merck | 1 | $1,000 |
| Koelis Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cysview$5,000
How this compares
$7,743 in reported general payments places this provider in the 75th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 12 | $5,593 |
| Tamsulosin Hcl | 38 | $746 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $148 |
| Ciprofloxacin Hcl | 13 | $53 |
| Levofloxacin | 13 | $36 |
Paid to pharmacies, not to this prescriber.
Other urology in Chapel Hill
- Culley CarsonChapel Hill$275K
- Mathew RaynorChapel Hill$61K
- Davis ViprakasitChapel Hill$37K
- Gopal NarangChapel Hill$31K
- David FriedlanderChapel Hill$26K
- David JohnsonChapel Hill$25K
- Marc RogersChapel Hill$12K
- Robert LippittSmithfield$11.4M
- Michael KennellyCharlotte$1.3M
- John KasparRaleigh$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.